Skip to content

Aldesulfone

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: aldapsone, aldesulfone sodium, diasone sodium, sodium aldesulphone, sodium sulfoxone, sulfoxone, sulfoxone sodium

OfmFDA approvedATC J04BA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Aldesulfone is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1974. DrugCentral lists 2 molecular targets, including folP1 and G6PD.

  • Approval status: ofm (first approved 1974 by the FDA).
  • Molecular targets: folP1 and G6PD (2 listed in DrugCentral).
  • ATC code: J04BA03 (Drugs for treatment of lepra).
  • Molecular formula: C14H16N2O6S3; molecular weight 404.47 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Dihydropteroate synthase 1folP1inhibitor—
Glucose-6-phosphate 1-dehydrogenaseG6PDunknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1974-05-24FDA—ABBVIE

ATC classification

ATC codeTherapeutic hierarchy
J04BA03ANTIINFECTIVES FOR SYSTEMIC USE › ANTIMYCOBACTERIALS › DRUGS FOR TREATMENT OF LEPRA › Drugs for treatment of lepra

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Aldesulfone is on its molecule page.

Molecular formulaC14H16N2O6S3
Molecular weight404.47 g/mol
CAS number144-75-2
InChIKeyNEDPPCHNEOMTJV-UHFFFAOYSA-N
PubChem CID5351
OS(=O)CNC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(NCS(O)=O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Aldesulfone work?

Its molecular targets in DrugCentral include folP1 (inhibitor) and G6PD.

When was Aldesulfone first approved?

Aldesulfone was first approved by the FDA in 1974.

What is the chemical formula of Aldesulfone?

Aldesulfone has the molecular formula C14H16N2O6S3 and a molecular weight of 404.47 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1974-05-24
AgencyFDA
Targets2
Indications0
FormulaC14H16N2O6S3
DrugCentral ID2533
Interactive profile